Epstein Secrets

ication, 8.41M) also have reports. J&J Says It Should Have Enough Doses For More Than 20M By End Of March. The Hill (2/22, Sullivan, 5.69M) reports Johnson & Johnson said Monday that it "plans to have enough doses of its vaccine for more than 20 million Americans by the end of March" if its vaccine is authorized

ate Republican Sens. Susan Collins of Maine and Mitt Romney of Utah said they would vote against confirming her." The AP notes that on Friday, Sen. Joe Manchin (D-WV) "became the first Democratic lawmaker to oppose the confirmation of Tanden." However, according to Reuters, even "with doubts growing about T

uccia, Subscription Publication, 8.41M), Politico (1/26, Cancryn, Roubein, 6.73M), and The Hill (1/26, Sullivan, Samuels, 5.69M) also have reports. Johnson & Johnson Expects To Report Vaccine Data Next Week. Reuters (1/26, Mishra, O'Donnell) reports that on Tuesday, Johnson & Johnson "said it expected to report

h did not come until two of the chamber's most conservative Democrats said they would vote against getting rid of the legislative filibuster." Sens. Joe Manchin (D-WV) and Kyrsten Sinema (D-AZ) have "said they would not vote to get rid of the filibuster, effectively ending the standoff." Axios (1/26, Peran

ew surge." Although the Times adds "experts aren't sure why vaccination rates have begun falling, or whether vaccine hesitancy, an issue before the Johnson & Johnson pause, is entirely to blame," Lilia Luciano reported on the CBS Weekend NewsVi (4/25, lead story, 2:30, Duncan, 1.24M) that a new CBS News poll "fin

gress In Infrastructure Talks. The Wall Street Journal (4/25, Leary, Subscription Publication, 8.41M) reports Sens. Shelley Moore Capito (R-WV) and Joe Manchin (D-WV) indicated there has been progress in talks over infrastructure legislation but were clear they do not support President Biden's $2.3 trillion